These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 19076145)
1. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study. Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145 [TBL] [Abstract][Full Text] [Related]
2. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. Culp S; Porter M BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age]. Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525 [TBL] [Abstract][Full Text] [Related]
4. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic. Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334 [TBL] [Abstract][Full Text] [Related]
5. Body mass index influences prostate-specific antigen in men younger than 60 years of age. Kim YJ; Han BK; Hong SK; Byun SS; Kim WJ; Lee SE Int J Urol; 2007 Nov; 14(11):1009-12. PubMed ID: 17956528 [TBL] [Abstract][Full Text] [Related]
7. Obesity and screening PSA levels among men undergoing an annual physical exam. Rundle A; Neugut AI Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231 [TBL] [Abstract][Full Text] [Related]
8. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL; Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472 [TBL] [Abstract][Full Text] [Related]
9. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. Freedland SJ; Platz EA; Presti JC; Aronson WJ; Amling CL; Kane CJ; Terris MK J Urol; 2006 Feb; 175(2):500-4; discussion 504. PubMed ID: 16406980 [TBL] [Abstract][Full Text] [Related]
10. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Kristal AR; Chi C; Tangen CM; Goodman PJ; Etzioni R; Thompson IM Cancer; 2006 Jan; 106(2):320-8. PubMed ID: 16342294 [TBL] [Abstract][Full Text] [Related]
11. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer. Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732 [TBL] [Abstract][Full Text] [Related]
12. Obesity-PSA relationship: a new formula. Hekal IA; Ibrahiem EI Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):186-90. PubMed ID: 20029402 [TBL] [Abstract][Full Text] [Related]
13. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program. Barqawi AB; Golden BK; O'Donnell C; Brawer MK; Crawford ED Urology; 2005 Apr; 65(4):708-12. PubMed ID: 15833513 [TBL] [Abstract][Full Text] [Related]
14. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175 [TBL] [Abstract][Full Text] [Related]
15. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer. Efstathiou JA; Chen MH; Renshaw AA; Loffredo MJ; D'Amico AV Cancer; 2007 Apr; 109(8):1493-8. PubMed ID: 17340594 [TBL] [Abstract][Full Text] [Related]
16. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Ochiai A; Fritsche HA; Babaian RJ Urology; 2005 Oct; 66(4):819-23. PubMed ID: 16230145 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer. Paranhos M; Antunes A; Andrade E; Freire G; Srougi M BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190 [TBL] [Abstract][Full Text] [Related]
18. The association of body mass index and prostate-specific antigen in a population-based study. Baillargeon J; Pollock BH; Kristal AR; Bradshaw P; Hernandez J; Basler J; Higgins B; Lynch S; Rozanski T; Troyer D; Thompson I Cancer; 2005 Mar; 103(5):1092-5. PubMed ID: 15668913 [TBL] [Abstract][Full Text] [Related]
19. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States. Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103 [TBL] [Abstract][Full Text] [Related]
20. Relationship of erythrocyte membrane polyunsaturated fatty acids and prostate-specific antigen levels in Jamaican men. Ritch CR; Brendler CB; Wan RL; Pickett KE; Sokoloff MH BJU Int; 2004 Jun; 93(9):1211-5. PubMed ID: 15180607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]